SLC7A11 and breast carcinoma: Metformin can inhibit the expression of the ubiquitin-like protein UFM1, which in turn suppresses the UFMylation of SLC7A11, leading to its reduced expression and induction of ferroptosis in breast cancer cells, thereby inhibiting cancer progression [46].